The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Jovan P. Antovic

Department of Surgical Sciences

Karolinska Institutet

Stockholm

Sweden

[email]@kirurgi.ki.se

Name/email consistency: high

[Claim this account]

Affiliations

Department of Surgical Sciences, Karolinska Institutet, Stockholm, Sweden. 2001 - 2003
Coagulation Research, Department of Surgical Sciences, Clinical Chemistry Laboratory L25, Karolinska Institutet, Sweden. 2002

References

Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay. Antovic, J.P., Antovic, A. Thromb. Haemost. (2003) [Pubmed]
Thrombin activatable fibrinolysis inhibitor (TAFI). A link between coagulation and fibrinolysis. Antovic, J.P. Clin. Lab. (2003) [Pubmed]
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?. Antovic, J., Bakic, M., Zivkovic, M., Ilic, A., Blombäck, M. Scand. J. Clin. Lab. Invest. (2002) [Pubmed]
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation. Antovic, J.P., Blombäck, M. Thromb. Res. (2002) [Pubmed]
Does thrombin activatable fibrinolysis inhibitor (TAFI) contribute to impairment of fibrinolysis in patients with preeclampsia and/or intrauterine fetal growth retardation?. Antovic, J.P., Rafik Hamad, R., Antovic, A., Blombäck, M., Bremme, K. Thromb. Haemost. (2002) [Pubmed]
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII. Antovic, J.P., Antovic, A., He, S., Tengborn, L., Blombäck, M. Haemophilia (2002) [Pubmed]
Activation of the coagulation system occurs within rather than outside cutaneous haemangiomas. Antovic, J., Bakic, M., Milicevic, R., Gojkovic, G., Blombäck, M. Acta Paediatr. (2001) [Pubmed]
Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A. Antovic, J., Schulman, S., Eelde, A., Blombäck, M. Haemophilia (2001) [Pubmed]